MLL-Rearranged Leukemias-An Update on Science and Clinical Approaches.

Winters AC, Bernt KM. · 2017

Read MLL-Rearranged Leukemias-An Update on Science and Clinical Approaches. by Winters AC, Bernt KM. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5299633.txt.

Introduction

Amanda C. Winters and Kathrin M. Bernt updated the science and treatment of MLL-rearranged leukemias in Frontiers in Pediatrics in 2017. The MLL1 gene sits on chromosome 11 and, when broken and fused to a partner gene, drives a distinctive group of acute leukemias. More than 80 partner genes are known, though about six account for most cases, and 10 percent of all leukemias carry these rearrangements.

Two groups dominate: infants under one year, mostly with acute lymphoblastic leukemia, and young to middle-aged adults, mostly with the myeloid form. A rarer group develops the disease from earlier chemotherapy. Outcomes remain poor compared with other leukemias. The review explains what the normal gene and its partners do, how fusions corrupt that work, and how patients present. It weighs current management, including when stem cell transplant helps, and points to targeted drugs against the fusion machinery as the most promising direction.

Catalog record

CREATORWinters AC, Bernt KM.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE132 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5299633

Browse the full library · About the Tower of Babel